The guard and Johnson's father, John Johnson, helped Seattle win its lone NBA title in 1979.
MIAMI – Acting Spurs coach Mitch Johnson has fond memories of Seattle Super Sonics great Gus Williams . The guard, who teamed with Johnson's father, forward John Johnson , to help the Sonics win the 1979 NBA title, died Jan. 15 nearly five years after suffering a stroke. He was 71.
Spurs focus on business over pleasure in Paris Williams, also a two-time All-Star, and John Johnson remained friends long after their playing days, the younger Johnson said. 'He was very close to my dad, kind of like a little brother of my dad's because he was younger on the team and my dad was a vet, so very close with him,' Mitch Johnson said of Williams, who was living in a care facility in the Baltimore area at the time of his death.
NBA Sonics Heat Washington Iowa Wolves G League Southern Cal Mitch Johnson John Johnson Gus Williams Riley Minix Riley Paris Williams All-Star The Wizard Seattle MIAMI Baltimore Austin Golden State N.Y. Mount Vernon All-Star
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Superman: Legacy's Score Will Blend John Williams' Theme With Original Music by John MurphyDirector James Gunn reveals that the upcoming Superman film will feature a unique blend of John Williams' iconic Superman theme and original music composed by John Murphy. Gunn emphasizes the importance of music in the film, stating that it was a key element from the beginning of the project.
Read more »
Aaron Taylor-Johnson and Sam Taylor-Johnson Celebrate End of 2024 with Romantic GetawayAaron Taylor-Johnson and his wife Sam Taylor-Johnson shared photos of their romantic vacation, showcasing intimate moments and breathtaking scenery. Aaron also shared shirtless photos, highlighting his physique.
Read more »
Johnson & Johnson's Lung Cancer Drugs Show Longer Survival Than AstraZeneca's TagrissoA clinical trial shows J&J's combination therapy extending survival for at least a year longer than Tagrisso. This breakthrough could change the treatment landscape for non-small cell lung cancer with EGFR mutations.
Read more »
Johnson & Johnson's Lung Cancer Drug Combo Shows Longer SurvivalJohnson & Johnson (J&J) announced that a combination of its lung cancer drugs, Rybrevant and Lazcluze, extended survival by at least a year compared to AstraZeneca's Tagrisso in a clinical trial. J&J aims to challenge Tagrisso's dominance as a leading treatment for non-small cell lung cancer with EGFR mutations.
Read more »
Johnson & Johnson Stock Hits Four-Year Low Amidst Rate Cut DoubtsJohnson & Johnson (JNJ) stock dropped to its lowest point in over four years on Wednesday, coinciding with a broader market decline fueled by expectations that the Federal Reserve may pause interest rate cuts due to a robust US labor market. Recent economic data, including strong job market indicators and an expanding services sector, have led investors to anticipate the Fed maintaining current interest rates. This development comes as JNJ received Fast Track status from the FDA for its Alzheimer's drug, posdinemab.
Read more »
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 BillionJohnson & Johnson unveils a major acquisition, purchasing Intra-Cellular Therapies for $14.6 billion to bolster its central nervous system disorder treatment portfolio. The deal focuses on Caplyta, a promising drug for schizophrenia and depression, with strong anticipated growth.
Read more »